...
首页> 外文期刊>Tissue engineering, Part A >Chitosan gel as an in situ-forming scaffold for rat bone marrow mesenchymal stem cells in vivo
【24h】

Chitosan gel as an in situ-forming scaffold for rat bone marrow mesenchymal stem cells in vivo

机译:壳聚糖凝胶作为大鼠骨髓间充质干细胞在体内的原位形成支架

获取原文
获取原文并翻译 | 示例

摘要

We herein formulated and characterized an in situ-forming chitosan gel consisting of chitosan and glycerol phosphate (GP) disodium salt, and examined its use as an in vivo scaffold for rat bone marrow mesenchymal stem cells (rBMSCs). First, the phase transition behaviors of chitosan solutions formulated with and without GP were characterized as a function of temperature. Chitosan solutions containing > 20 wt% GP became a gel at 37°C and maintained this form for 28 days in vitro and in vivo. Next, we examined whether the chitosan gel could act as a suitable biocompatible substrate for the attachment and proliferation of rBMSCs. Immunohistochemistry clearly demonstrated that rBMSCs survived well on the scaffold created by in situ-forming chitosan gel in rats. Injection of chitosan gel alone induced macrophage accumulation in the host tissue and at the edge of the chitosan, whereas injection of chitosan gel containing rBMSCs was associated with decreased macrophage accumulation, indicating immunosuppression by the transplanted rBMSCs. Our results collectively show for the first time that chitosan gel could serve as an in situ-forming gel scaffold for entrapped rBMSCs in vivo.
机译:我们在本文中配制并表征了由壳聚糖和磷酸甘油(GP)二钠盐组成的原位形成的壳聚糖凝胶,并检查了其作为大鼠骨髓间充质干细胞(rBMSC)的体内支架的用途。首先,用和不用GP配制的壳聚糖溶液的相变行为被表征为温度的函数。包含> 20 wt%GP的壳聚糖溶液在37°C时变成凝胶,并在体外和体内将这种形式维持28天。接下来,我们检查了壳聚糖凝胶是否可以充当rBMSC附着和增殖的合适生物相容性底物。免疫组织化学清楚地表明,rBMSC在大鼠原位形成壳聚糖凝胶所产生的支架上存活良好。单独注射脱乙酰壳多糖凝胶可诱导巨噬细胞在宿主组织中和在脱乙酰壳多糖的边缘积累,而注射含rBMSCs的脱乙酰壳多糖凝胶则可减少巨噬细胞的积累,表明被移植的rBMSC免疫抑制。我们的研究结果首次集体表明,壳聚糖凝胶可作为体内捕获的rBMSCs的原位形成凝胶支架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号